AI medical stock landing MASSIVE contracts

Because it used new technology - surgical robotics - to drive sales sky high.......................................................................................................................................................................................................................... [Unsubscribe]( Dear Reader, Few people know its name, but Intuitive Surgical was one of the five best stocks of the last 20 years. It went up as much as 18,000% in two decades. Why? Because it used new technology - surgical robotics - to drive sales sky high. Now... [another company is following its path.]( The company is tiny today - just $500 million - but it is in position to grow dramatically. In short, it is [the inventor of the world's first AI-designed drug to enter clinical trials.]( And big pharma is lining up to use its patent-protected technology. - Merck is collaborating with them on three projects that could generate up to $674 million in revenue. - French pharma giant Sanofi agreed to pay the company up to $5.2 billion to develop 15 new drugs. - Bristol Meyers Squibb signed a $1.2 billion partnership with the company. You can see... each one of these projects is worth more than the entire market cap of this new AI stock! In short, the upside is MASSIVE. Which is why I wanted to send you [this video.]( [Click to Play the video.]( It comes from one of the great stock pickers of all-time - a man who actually recommended Intuitive Surgical in real time back in 2004. In fact, he called 4 of the top 6 performing stocks from 2000 to 2020. And he says this new company is the #1 AI Stock Under $10. [Watch his free video breaking down the situation here.]( Sincerely, Rachel Gearhart Associate Publisher, The Oxford Club This ad is sent on behalf of The Oxford Club, 105 W. Monument Street Baltimore, MD 21201. If you would like to opt out from receiving offers from The Oxford Club, [please click here]( --------------------------------------------------------------- This is a PAID ADVERTISEMENT provided to the subscribers of StockEarnings Free Newsletter. Although we have sent you this email, StockEarnings does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click [Unsubscribe]( . StockEarnings, Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA W: 877.6.STOCKS StockEarnings.com [Today's Bonus Content: Tiny Biotech Scores $130M from Bezos: Is This Your Next Investment?](